ALGERNON PHARMACEUTICALS
Breathtec Biomedicala medical diagnostics company focused on developing, in-licensing, and commercializing proprietary innovative. Breathtec Biomedical (“Breathtec”) was formed to propel innovative research in the area of breath analysis as a medical screening tool. Their efforts are aimed at leading the development of commercially viable methods for the early screening of diseases such as lung and breast cancers, neurodegenerative diseases like Alzheimer's, Parkinson's, tuberculosis, diabetes, liver disease, and more.
ALGERNON PHARMACEUTICALS
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2015-01-01
Address:
Delta, Ontario, Canada
Country:
Canada
Website Url:
http://www.algernonpharmaceuticals.com
Total Employee:
1+
Status:
Active
Contact:
+1 (604) 805-4602
Email Addresses:
[email protected]
Total Funding:
12.94 M USD
Technology used in webpage:
Thai Server Location
Similar Organizations
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Current Employees Featured
Founder
Stock Details
Investors List
Bullrun Capital Inc
Bullrun Capital Inc investment in Post-IPO Equity - Algernon Pharmaceuticals
MTbrain
MTbrain investment in Venture Round - Algernon Pharmaceuticals
Official Site Inspections
http://www.algernonpharmaceuticals.com Semrush global rank: 11.51 M Semrush visits lastest month: 156
- Host name: ec2-174-129-30-187.compute-1.amazonaws.com
- IP address: 174.129.30.187
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Algernon Pharmaceuticals"
About Us - Algernon Pharmaceuticals Inc.
New Chemical Entity (NCE) Development Pathway and Failure Rates. Repurposing existing, safe, small molecules to treat different disease applications requires lower capital investment, has a reduced risk of failure due to toxicity …See details»
Company Information :: Algernon Pharmaceuticals Inc. (AGN)
Company Contact Algernon Pharmaceuticals Inc. 601 West Broadway Suite 400 Vancouver, BC V5Z 4C2 Canada T: 604-398-4175See details»
Investors :: Algernon Pharmaceuticals Inc. (AGN)
[email protected]. Investor Relations. Christopher J. Moreau Chief Executive Officer T: 604-398-4175 [email protected]. Transfer Agent. TSX Trust …See details»
Algernon Pharmaceuticals - Overview, News & Similar ... - ZoomInfo
Algernon Pharmaceuticals has announced that James Kinley will be joining the organization as Chief Financial Officer, effective December 1, 2021. Previously, Kinley served as Chief …See details»
Algernon Pharmaceuticals Company Profile | Management and
Www.algernonpharmaceuticals.com Algernon Pharmaceuticals Profile and History Algernon Pharmaceuticals is a clinical stage pharmaceutical development company focused on the …See details»
Algernon Pharmaceuticals Inc. - LinkedIn
Algernon Pharmaceuticals Inc. | 1,086 followers on LinkedIn. A clinical stage pharmaceutical development company | CSE: AGN | FRANKFURT: AGW | OTCQB: AGN | Algernon …See details»
Algernon Pharmaceuticals Company Description - Stock Analysis
Dec 6, 2024 Algernon Pharmaceuticals Inc. operates as a clinical stage pharmaceutical development company. It focuses on the areas of non-alcoholic steatohepatitis, chronic kidney …See details»
Algernon Pharmaceuticals - VentureRadar
Website: https://algernonpharmaceuticals.com/ Develops clinical stage pharmaceuticals targeting non-alcoholic steatohepatitis, chronic kidney disease, inflammatory ...See details»
Algernon Pharmaceuticals Inc. | CSE - Canadian Securities Exchange
Algernon Pharmaceuticals is a drug re-purposing company that investigates safe, already approved drugs for new disease applications, moving them efficiently and safely into new …See details»
Company Algernon Pharmaceuticals Inc. - MarketScreener.com
Sep 21, 2007 Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic …See details»
Management Team :: Algernon Pharmaceuticals Inc. (AGN)
Mr. Moreau is the CEO of Algernon Pharmaceuticals Inc. and a member of the company's board of directors. With over 30 years of executive management experience, including 15 years in …See details»
Algernon Pharmaceuticals Inc.: Contact Details and ... - RocketReach
Algernon Pharmaceuticals Inc. is a Pharmaceutical Manufacturing, Drug Manufacturing & Research, and Biotechnology company located in Vancouver, British Columbia with 11 …See details»
Algernon Pharmaceuticals - Craft
Oct 29, 2024 Algernon Pharmaceuticals is a clinical-stage pharmaceutical development company focused on the areas of non–alcoholic steatohepatitis, chronic kidney disease, …See details»
Algernon Pharmaceuticals - PitchBook
Algernon Pharmaceuticals General Information Description. Algernon Pharmaceuticals Inc is a clinical-stage drug development company focused on the disease areas of stroke, idiopathic …See details»
Algernon Pharmaceuticals Inc. - Canadian Securities Exchange
Algernonpharmaceuticals.com Algernon Pharmaceuticals is a drug re-purposing company that investigates safe, already approved drugs for new disease applications, moving them …See details»
Algernon Pharmaceuticals - Products, Competitors, Financials, …
Algernon Announces Warrant Extension. Nov 5, 2024. Algernon Announces Warrant Extension THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR …See details»
Board of Directors :: Algernon Pharmaceuticals Inc. (AGN)
Mr. Moreau is the CEO of Algernon Pharmaceuticals Inc. and a member of the company's board of directors. With over 30 years of executive management experience, including 15 years in …See details»
Algernon Pharmaceuticals Receives Notice of Allowance from
13 hours ago [email protected] [email protected] www.algernonpharmaceuticals.com. Neither the Canadian Securities Exchange nor its Market …See details»
Algernon Pharmaceuticals Receives Notice of Allowance from …
13 hours ago VANCOUVER, British Columbia, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) …See details»
Algernon NeuroScience :: Algernon Pharmaceuticals Inc. (AGN)
1 Source: The World Stroke Organization (WSO) 2 Source: National Institute of Neurological Disorders and Stroke. Featured Video. Algernon Pharmaceuticals CEO Christopher J. Moreau …See details»